Package Leaflet: Information for the User
Navixen Plus 600 mg/12.5 mg film-coated tablets
eprosartan and hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet, you may need to read it again.
Contents of the pack and other information
Contents of the pack and other information
Navixen Plus is used:
Navixen Plus contains two active substances, eprosartan and hydrochlorothiazide.
You will only take Navixen Plus if your blood pressure does not decrease sufficiently with eprosartan alone.
Do not take Navixen Plus if:
Do not take Navixen Plus if any of the above applies to you. If you are not sure, consult your doctor or pharmacist before taking this medicine.
Warnings and precautions
Consult your doctor, pharmacist or nurse before starting to take Navixen Plus if:
- an angiotensin-converting enzyme inhibitor (ACE inhibitor) (e.g. enalapril, lisinopril, ramipril), especially if you have kidney problems related to diabetes.
- aliskiren
Your doctor may check your kidney function, blood pressure and blood electrolyte levels (e.g. potassium) at regular intervals.
See also the information under the heading "Do not take Navixen Plus".
If any of the above applies to you (or you are not sure), consult your doctor or pharmacist before taking this medicine.
Treatment with hydrochlorothiazide may cause an electrolyte imbalance in your body. Your doctor should regularly monitor the electrolytes in your blood.
Consult your doctor if you experience abdominal pain, nausea, vomiting or diarrhea after taking Navixen Plus. Your doctor will decide whether to continue treatment. Do not stop taking Navixen Plus on your own.
Children and adolescents
Navixen Plus should not be given to children and adolescents under 18 years of age.
Operations and tests
Consult your doctor or pharmacist before taking this medicine if you are scheduled to have:
Taking Navixen Plus with other medicines
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. This includes medicines obtained without a prescription, including herbal remedies. This is because this medicine may affect the way other medicines work. Also, some medicines may affect the way Navixen Plus works.
In particular, consult your doctor or pharmacist if you are taking:
If any of the above applies to you (or you are not sure), consult your doctor or pharmacist before taking this medicine.
Your doctor may need to change your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings "Do not take Navixen Plus" and "Warnings and precautions".
The following medicines may decrease the effect of Navixen Plus:
If any of the above applies to you (or you are not sure), consult your doctor or pharmacist before taking Navixen Plus.
The following medicines may increase the effect of Navixen Plus:
If any of the above applies to you (or you are not sure), consult your doctor or pharmacist before taking this medicine.
If you are taking any of the following medicines, your doctor may perform blood tests:
Consult your doctor or pharmacist before taking this medicine. Depending on the results of your blood tests, your doctor may decide to change your treatment with these medicines or Navixen Plus.
Taking Navixen Plus with food, drinks and alcohol
Drinking alcohol while taking this medicine may lower your blood pressure and make you feel tired or dizzy.
Consult your doctor before taking Navixen Plus if you are on a low-salt diet.
Not having enough salt can cause your blood volume or sodium levels in your blood to be lower.
Pregnancy
Breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
Navixen Plus is unlikely to affect your ability to drive or use tools or machines. However, you may feel drowsy or dizzy while taking this medicine. If this happens, do not drive or use tools or machines and consult your doctor.
Navixen Plus contains lactose (a type of sugar)
If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.
Follow exactly the instructions of administration of this medicine given to you by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Taking this medicine
How to take it
Adults
The usual dose is one tablet a day.
Use in children and adolescents
Navixen Plus should not be given to children and adolescents under 18 years of age. The safety and efficacy have not been established.
If you take more Navixen Plus than you should
In case of overdose or accidental ingestion, contact the Toxicology Information Service, phone: 91.562.04.20, consult your doctor or go to a hospital immediately.
Take the medicine pack with you. The following effects may occur:
If you forget to take Navixen Plus
If you forget to take a dose, take it as soon as you remember.
If you forget to take a dose and it is almost time for your next dose, skip the missed dose.
Do not take a double dose to make up for forgotten doses.
If you stop taking Navixen Plus
Do not stop taking Navixen Plus without consulting your doctor first.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The following adverse effects may appear with this medicine:
Allergic Reactions
If you have an allergic reaction, stop taking Navixen plus and see a doctor immediately. The symptoms may include:
Other possible adverse effects of Navixen plus include:
Very Common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very Rare(may affect less than 1 in 10,000 people)
acute respiratory distress syndrome (signs include severe respiratory distress, fever, weakness, and confusion).
Frequency Not Known(frequency that cannot be estimated from the available data):
Lack of appetite, jaundice, decreased vision or eye pain due to high pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma], feeling restless, changes in blood cell count: decreased granulocytes and platelets, alterations in red blood cell formation; decreased magnesium level in the blood, increased calcium and triglyceride levels in the blood, kidney disorders, kidney inflammation, acute kidney failure, inflammation of the blood vessel walls, bubble formation on the skin including dead skin cells (toxic epidermal necrolysis), rash/lesions on the skin usually in sun-exposed areas due to an autoimmune disease (cutaneous lupus erythematosus), systemic lupus erythematosus, joint pain (arthralgia), severe allergic reactions (anaphylactic reactions), increased sensitivity to sunlight (photosensitivity), skin and lip cancer (non-melanoma skin cancer). Intestinal angioedema: inflammation in the intestine has been reported, presenting symptoms such as abdominal pain, nausea, vomiting, and diarrhea after using similar products.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the box after CAD or EXP. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the containers and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. This way, you will help protect the environment.
Composition of Navixen Plus
Appearance of the Product and Package Contents
Coated tablets for oral use, white-yellowish in color and capsule-shaped.
The tablets have the inscription “5147” on one of the faces.
Navixen Plus is packaged in blisters in boxes containing 28 or 56 tablets or in a clinical package of 280 (28x10) tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Viatris Healthcare Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Manufacturer
Mylan Laboratories SAS
Route de Belleville Lieu dit Maillard
F- 01400 Châtillon-sur-Chalaronne, France
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.
C/ General Aranaz, 86
28027 Madrid
Spain
Date of the Last Revision of this Prospectus:January 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/
The average price of NAVIXEN PLUS 600 mg/12.5 mg FILM-COATED TABLETS in October, 2025 is around 24.82 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.